Precision Oncology in Pancreatic Cancer. From Surgery- to Genetic-Based Chemotherapy

Ismael Domínguez-Rosado; Jorge Meléndez-Zajgla

doi:10.24875/RIC.20000233

Precision Oncology in Pancreatic Cancer. From Surgery- to Genetic-Based Chemotherapy

Rev Invest Clin. 2020 Dec 22;72(6):333-336. doi: 10.24875/RIC.20000233.

Authors

Ismael Domínguez-Rosado¹, Jorge Meléndez-Zajgla²

Affiliations

¹ Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
² Basic Research Subdirectorate, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.

PMID: 33057318
DOI: 10.24875/RIC.20000233

Abstract

Pancreatic ductal adenocarcinoma is one of the most lethal forms of solid tumors. These tumors arise from the exocrine component of the pancreas, probably from acinar stem cells1-3.

MeSH terms

Carcinoma, Pancreatic Ductal / drug therapy*
Carcinoma, Pancreatic Ductal / genetics
Carcinoma, Pancreatic Ductal / surgery*
Humans
Pancreatic Neoplasms / drug therapy*
Pancreatic Neoplasms / genetics
Pancreatic Neoplasms / surgery*
Precision Medicine*